Background. The diagnosis of tuberculosis in human immunodeficiency virus (HIV)-infected children is challenging. We assessed the performance of alternative specimen collection methods for tuberculosis diagnosis in HIV-infected children using Xpert MTB/RIF (Xpert).
In 2014, the World Health Organization (WHO) estimated the annual burden of childhood tuberculosis to be 1 million cases and 140 000 deaths, representing 10% and 9% of global caseload and mortality, respectively [1] . These updated figures, which are based on recent modeling and statistical estimates, highlight the gap between the global caseload and cases reported to WHO [2, 3] . Childhood tuberculosis is indeed underdiagnosed and underreported due to the challenging diagnostic confirmation that is inherent in the paucibacillary nature of the disease and the difficulty in obtaining expectorated sputum from children [4] .
Diagnosis is even more challenging in human immunodeficiency virus (HIV)-infected children due to the low specificity of clinical and radiological features and the low sensitivity of tuberculin skin tests that are used in various scores and diagnostic approaches [5] . These difficulties occur in a context of more severe clinical presentations, co-treatment issues and challenges, and higher mortality, which further justify rapid diagnosis and treatment [6, 7] .
WHO endorsed the automated nucleic acid amplification test (NAAT) Xpert MTB/RIF (Xpert; Cepheid, Sunnyvale, California) in 2010 for the diagnosis of HIV-associated and drug-resistant tuberculosis in adults [8, 9] . A recent metaanalysis showed its performance for rapid diagnosis of culture-confirmed pulmonary tuberculosis in children [10] . These findings support the revised WHO recommendations on scaling-up the use of Xpert in children [11] . However, in children, not only the assay but also the specimen collection methods, their feasibility, and their ability to retrieve bacilli are key factors that contribute to the microbiological diagnosis of tuberculosis. Standard samples recommended by WHO include expectorated sputum, which is not feasible in young children; gastric aspirate, which requires fasting and, most often, hospitalization; and induced sputum [11] [12] [13] . To date, the implementation of methods to collect samples in children unable to expectorate remains very limited. Of 651 pediatric HIV sites surveyed in sub-Saharan Africa in 2012, only 6% had the capacity to sample induced sputum and only 5% had the capacity to sample gastric aspirates, while 87% had smear microscopy and 54% had mycobacterial culture capacities [14] . As Xpert is rolled out in national programs, the limited capacity to implement specimen collection in children restricts the impact of the near point-of-care introduction of the Xpert assay [9, 15, 16] .
Here, we determined whether the use of Xpert with a combination of alternative specimen collection methods not yet recommended by WHO or national programs, including nasopharyngeal aspirates, a string test, and stool samples, would be effective to diagnose tuberculosis in HIV-infected children.
METHODS

Study Design and Participants
We conducted a prospective cohort study in 8 hospitals in Burkina Faso, Cambodia, Cameroon, and Vietnam (see Supplementary Appendix). From April 2011 to August 2013, HIV-infected children aged ≤13 years with a suspicion of intrathoracic tuberculosis based on at least 1 of the following: persistent cough; persistent fever; failure to thrive, defined as recent deviation in the growth curve or a weight-for-age Z score < −2 standard deviation; failure of broad spectrum antibiotics for a pulmonary infection; or suggestive chest radiograph anomaly were enrolled in the study after receipt of parent or guardian informed consent. Children with a history of tuberculosis treatment started within 2 years prior to the study were not eligible.
Each country's national ethics committee or relevant institutional review board approved the study.
Procedures
All children underwent a complete physical exam, a chest radiograph with standard anteroposterior view for all ages and an additional lateral view for children aged <5 years, a baseline blood sample including HIV viral load and CD4 count, and a tuberculin skin test.
Bacteriological samples were taken using standard collection methods that consisted of 2 gastric aspirates in children aged <10 years and 3 expectorated sputum samples in those aged ≥10 years, as well as alternative methods that involved the collection of 1 nasopharyngeal aspirate and 1 stool sample for all ages and 1 string test for those aged ≥4 years. For children aged <4 years, the string test was replaced by collection of a third gastric aspirate. Trained nurses collected specimens in the early morning after overnight fasting, using standardized procedures (see Supplementary Appendix 3). Gastric aspirates were neutralized with 8% sodium bicarbonate. A gastric lavage with 10 mL sterile water was performed if spontaneous aspirate could not be obtained. Nasopharyngeal aspiration was performed without prior nasal instillation using a mucus aspirator connected to a suction device in order to stimulate the cough reflex and obtain 2-5 mL of mucus [16] . The string test was performed using the pediatric Entero-Test (HDC Corporation, Milpitas, California) [17, 18] . The gelatin capsule was swallowed, unraveling a 90-cm absorbent nylon string, and the nonabsorbent part of the string was taped to the cheek with plaster. After an intragastric downtime of 2 hours, the string was retrieved and the absorbent part was deposited in a Falcon tube containing 3 mL 0.9% saline.
Samples were transported in ice chests to laboratories within 4 hours of collection. All samples were decontaminated with N-acetyl-L-cysteine and sodium hydroxide and centrifuged; stool samples were previously prepared by dilution in sterile water. Centrifuged pellets were resuspended in phosphate buffer. Direct exam was performed using the Ziehl-Neelsen method for stool samples and fluorescent (auramine) microscopy from a drop of pellet suspension was performed for all other samples. Sample pellet suspensions were inoculated in Lowenstein-Jensen slants and/ or cultured using automated liquid culture (Bactec MGIT; Becton Dickinson, Maryland). Isolates were identified as Mycobacterium tuberculosis complex by Ziehl-Neelsen staining and biochemical method, immunochromatographic tests, or commercial multiplex line-probe assays (see Supplementary Appendix).
The Xpert assay was performed on 1.0 mL of fresh sample or decontaminated pellet if the sample volume was not sufficient, following the manufacturer's recommendations. Stool samples were previously processed by emulsification of 0.5 g of material in Sheather's solution (28% sucrose in distilled water), filtered through funnel gauze, and centrifuged (see Supplementary Appendix). Because Xpert was not available at study onset at 2 sites, the assay was retrospectively performed on frozen samples for some of the children.
Xpert results for all samples, if performed prospectively, were available to the treating physician for diagnosis. All children were followed for 6 months during the study, with visits at 1, 2, 3, and 6 months following inclusion. Antiretrovirals and antituberculosis treatment were initiated per national guidelines and provided by national programs.
Statistical Analysis
We used culture on any of the samples as the reference standard for calculation of sensitivity and specificity. In addition, we classified tuberculosis using the Intrathoracic Tuberculosis Definitions for Diagnostic Research in Children as confirmed, probable, or possible tuberculosis or tuberculosis unlikely and not tuberculosis [19] . Chest radiographs were reviewed independently by 2 readers blinded to clinical and biological data; discordant opinions were resolved by a third reader.
We analyzed the data using both the intention-to-diagnose approach, considering any child with at least 1 Xpert performed on any specimen, and the per-protocol approach, restricting analyses to children with Xpert performed per protocol on all specimens [20] . We assessed the diagnostic accuracy of Xpert for confirmed tuberculosis by measuring sensitivity and specificity and their exact binomial 95% confidence intervals (CIs) for different sample combinations. Nonevaluable results included missing tests, either because the specimen was not collected or the test itself was not performed, and indeterminate tests results. In the intention-to-diagnose analysis, we considered nonevaluable results as negative. We compared performance of Xpert on alternative specimens and the standard specimen using McNemar's χ 2 test. All analyses were performed using Stata 13 software (StataCorp, College Station, Texas).
RESULTS
Study Population
We enrolled 281 children, 272 (96.8%) of whom had at least 1 sample collected and tested with Xpert (intention-to-diagnose population; Figure 1 ). Figure 1 ). Of the 93 children without complete Xpert results, 4 died before completion of specimen collection, 29 had all samples collected but Xpert not performed, and 60 had at least 1 sample not collected, including 30 who were unable to swallow the string for the string test and 9 for whom this procedure was unsuccessful due to vomiting.
Smear microscopy was positive on at least 1 sample in 18 (6.6%) children, of whom 14 of smear positive had culture-confirmed (Table 3) , 3 (2.6%) of 116 probable tuberculosis cases, 2 (2.0%) of 100 possible tuberculosis cases, and 1 (3.7%) of 27 tuberculosis unlikely or not tuberculosis cases ( Table 5 ). The intention-to-diagnose sensitivity of Xpert was 23/29 (79.3%; 95% CI, 60.3-92.0) overall, 14/14 (100%; 95% CI, 76.8-100) in smear-positive and 9/15 (60.0%; 95% CI, 32.3-83.7) in smear-negative culture-confirmed tuberculosis ( Table 3 ). The characteristics of the 6 Xpert-positive culturenegative children are shown in the Supplementary Appendix, Table 5 .
Performed on alternative or standard samples, Xpert yielded an identical number of 25 cases. The sensitivity of Xpert on alternative samples (22/29; 75.9%; 95% CI, 56.5-89.7) did not differ significantly from that obtained on standard samples (21/29; 72.4%; 95% CI, 52.8-87.3, P = .08). Paired nasopharyngeal aspirate and stool samples were collected in 248 (91.2%) children, and at least 1 of the 2 samples was collected in 272 (100%) children; with this combination, 22 culture-confirmed cases were detected. Compared with nasopharyngeal aspirates, Xpert on stools had an incremental sensitivity of 10% (20/29 to 22/29) and an incremental yield of 14% (21 to 24). Xpert on the string test had no incremental sensitivity but an incremental yield of 4.5% (24 to 25 cases detected).
In the per-protocol population, the sensitivity of Xpert was 81.3% (95% CI, 54.4-96.0) ( Table 4 ). Xpert performed similarly on alternative and standard samples (sensitivity: 12/16; 75.0%; 95% CI, 47.6-92.7 vs 13/16; 81.3%; 95% CI, 54.4-96.0; P = .31), with a specificity above 98% overall.
Of 29 children with confirmed tuberculosis, 1 had rifampin resistance that was not detected by Xpert. Conversely, Xpert detected rifampin resistance in 1 child who remained culture negative and was considered cured on first-line tuberculosis treatment.
Xpert results were available at the time of diagnosis in 130 (48.5%) of 268 children. Xpert was positive in 17 patients, all diagnosed as having tuberculosis by a clinician prior to the availability of results. Among children with Xpert performed secondarily, 4 were diagnosed and initiated tuberculosis treatment after receipt of positive Xpert results. Two children had positive Xpert results but died before treatment initiation.
DISCUSSION
In the PAANTHER study, Xpert used on a combination of nasopharyngeal aspirate, stool sample, and string test had diagnostic performance that was similar to that for Xpert used on either gastric aspirate or expectorated sputum sample, which is usually recommended by national tuberculosis programs. This is the first multicenter study to assess Xpert on a large number of respiratory specimens from different sites and stool samples exclusively in HIV-infected children who present specific diagnostic and therapeutic challenges. We analyzed our results in an intention-to-diagnose approach, which provided better estimates of the operational sensitivity of the proposed strategies compared with a per-protocol approach; this is a key issue in this challenging population [21] .
With an overall sensitivity of 79% for Xpert used on all samples and similar sensitivities on alternative and standard sample combinations, we show that Xpert performs equally well in HIV-infected children compared with HIV-uninfected children [10] . Our results are consistent with the 70% pooled sensitivity in HIV-infected children found by the metaanalysis of 15 studies on respiratory samples [10] . Xpert detected all smear-positive culture-confirmed tuberculosis cases and 60% of smearnegative culture-confirmed cases, which is in line with the pooled sensitivity results from the metaanalysis. There was a high proportion (14/29, 48%) of smear-positive culture-confirmed tuberculosis in these HIV-infected children, which may reflect more severe forms of tuberculosis and higher bacterial loads. Children enrolled in the study had severe clinical presentations, with more than two-thirds of children underweight, and there were early deaths. In the group with samples missing, some due to early death, the culture yield was higher than in the 
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Tuberculosis Confirmed Tuberculosis Probable Tuberculosis Possible Tuberculosis Unlikely and Not Tuberculosis (n = 272) n (%) (n = 29) n(%) (n = 116) n (%) (n = 100) n (%) (n = 27) n (%) per-protocol group, highlighting the importance of rapid and adapted testing strategies in this population with severe clinical features. The specificity of Xpert was very high overall, which reflects its inability to detect Mycobacterium tuberculosis in culture-negative children and is a current limitation of the assay [10] . Xpert nevertheless detected tuberculosis in 3 culturenegative symptomatic probable and possible tuberculosis cases. The performance of Xpert with alternative samples was identical to that with standard samples, with similar overall yield (25 cases) and sensitivity for culture-confirmed tuberculosis. This suggests that these samples have a potential to replace or complement standard samples if standard samples are challenging to implement, for example, collection of sputum samples in young children or collection of gastric aspirates. For both types of specimen, overall performance was based on incremental yield and sensitivity of multiple samples.
To our knowledge, this is the first study to show large-scale results of stool testing with Xpert for the diagnosis of intrathoracic tuberculosis after 2 pilot studies from South Africa [22, 23] . Stool samples make it possible to retrieve bacilli from respiratory origin; their interest in tuberculosis diagnosis has been shown both with culture and other NAATs [24] [25] [26] . Xpert performed on 1 stool sample had intention-to-diagnose and per-protocol sensitivities of 62.1% and 68.8%, respectively, which confirmed promising results from the 2 South African studies. As shown previously, culture yield in stool was low, which may be due to decontamination methods and rates of contaminated cultures [25, 27] . Use of a flotation method based on sucrose, an inexpensive and easily accessible consumable, may have contributed to the performance of Xpert on stool samples.
Despite previous findings that showed that the string test performed better than induced sputum for smear-negative HIVinfected adults [18] and had a very good acceptability in children aged ≥4 years [17] , its performance in our study was disappointing. Its per-protocol sensitivity was 69%; however, a high failure rate hampered its overall performance. It detected none of the smear-negative culture-confirmed cases but had a 4.5% incremental yield by detecting 1 additional culture-negative child.
Conversely, nasopharyngeal aspirate had excellent feasibility and good diagnosis accuracy when tested with Xpert. Previous studies showed that it had similar sensitivity to induced sputum despite lower culture yield [28, 29] . In our study, its sensitivity as a single test was similar to the 70% pooled sensitivity found by the metaanalysis in HIV-positive children and slightly better than previous studies, probably due to the high smear-positivity rate. This well-tolerated method is of particular interest as it does not require a child to fast, unlike gastric aspirates, and is better tolerated than induced sputum in children with severe respiratory deficit [16] . WHO recommended Xpert as a replacement test for tuberculosis diagnosis in children in 2013 but gave no clear recommendations on the optimal specimen collection strategy [30] . In our study, 100% of children had at least 1 nasopharyngeal aspirate or 1 stool sample performed, and this combination had sensitivity (75.9%) and yield (24 cases) that were similar to those of standard specimens. Both methods could be recommended for large-scale implementation of childfriendly methods for performance of NAATs in children unable to expectorate sputum, as routine implementation of gastric aspirates remains poorly accepted and induced sputum is challenging [14] . Furthermore, collection of nasopharyngeal aspirate and stool sample is suitable for younger children [23, 28] . However, at this stage, stool processing for Xpert is complex and time consuming; an optimized centrifugation-free process for stool preparation would facilitate its implementation at the near point-of-care level. Whether our results apply to a predominantly HIV-uninfected population warrants further studies as they may present with lower proportions of smearpositive tuberculosis [10] .
There are limitations to our study. First, in terms of a reference standard, heterogeneity in culture methods led to differential verification; availability of solid culture only in Burkina Faso may have contributed to a higher rate of culture-negative Xpertpositive cases. Use of case definitions not specifically developed for HIV-infected children may also have led to the high rate of probable and possible tuberculosis in our study population [19] . Second, Xpert was performed retrospectively in some of the children and was therefore not always available to clinicians, which may explain why children with positive Xpert results were classified as possible tuberculosis if they were not initially started on treatment. Finally, we chose not to test induced sputum due to practical challenges in the nebulization process and concerns about nosocomial transmission and therefore were unable to compare results from alternative samples with those of induced sputum, which showed consistently high yields both with culture and NAAT [29, 31] . Xpert was, however, equally effective with induced sputum and with expectorated sputum and gastric aspirates, which were used as standard samples in our study [10] .
Due to the nature of childhood tuberculosis, microbiological confirmation has its limitation. The accuracy of Xpert in children is still suboptimal compared with its performance in adults [10, 32] . In our study, Xpert detected only 26 of 145 confirmed and probable tuberculosis cases. It primarily confirmed clinical diagnosis but also made it possible to diagnose tuberculosis that had been undetected on routine exams in 4 children. The ongoing development of new NAATs such as Xpert Ultra with an expected lower limit of detection could impact significantly the capacity to reach diagnosis confirmation. An empirical treatment decision based on clinical and radiological features remains frequent in children but challenging in the context of HIV infection due to other opportunistic infections or diseases. 
